RMD Open | A leading rheumatology journal from EULAR & BMJ

Intro Pullout Text Widget

Publishes open access original research in rheumatology

An official journal of EULAR

RMD Open publishes high quality peer-reviewed original research covering the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases, including osteoporosis, spine and rehabilitation. Clinical and epidemiological research, basic and translational medicine, interesting clinical cases, and smaller studies that add to the literature are all considered.

It is an online only open access journal that aims to provide rapid publication of research through a continuous publication model. All submitted content is subject to peer review prior to publication. Published work is free to read.

RMD Open is an official journal of EULAR. You can keep up with the latest news via Twitter and Facebook.

Listen to the ARD and RMD Open podcast and subscribe in all podcast platforms, including Apple Podcasts, Google Podcasts and Spotify.

Scopus CiteScore: 5.4 (2019)

MEDLINE indexed

Editor-in-Chief: Professor Bernard Combe, CHU Lapeyronie, France
Editorial team

COVID-19: a message from BMJ >>

Current Issue

Authors

RMD Open considers submissions of a variety of article types, including original articles, short reports and clinical cases.

Information is also provided on editorial policies and open access.

This is an open access journal that levies an Article Publishing Charge (APC). Discounts and waivers are available; details are provided in the Author Information section.

All manuscripts should be submitted online.

Published articles are discoverable via PubMed, Scopus and Google Scholar.

Author information

Submit a paper

Intro Pullout Text Widget

Authors

Latest Articles

Vasculitis:

Cardiovascular drug treatment, statins and biopsy-confirmed giant cell arteritis: a population-based case–control study

Spondyloarthritis:

Reactive arthritis after COVID-19 infection

Rheumatoid arthritis:

Identifying the preferable rheumatoid arthritis subgroups for intervention with the anti-RANKL antibody denosumab to reduce progression of joint destruction

Lupus:

Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment

Spondyloarthritis:

Dual neutralisation of IL-17F and IL-17A with bimekizumab blocks inflammation-driven osteogenic differentiation of human periosteal cells

Most Read Articles

Miscellaneous:

Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic

Miscellaneous:

Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin

Inflammatory arthritis:

Increased primary care use for musculoskeletal symptoms, infections and comorbidities in the years before the diagnosis of inflammatory arthritis

Psoriatic arthritis:

Relationship of pain and fatigue with health-related quality of life and work in patients with psoriatic arthritis on TNFi: results of a multi-national real-world study

Spondyloarthritis:

Predictors of extra-articular manifestations in axial spondyloarthritis and their influence on TNF-inhibitor prescribing patterns: results from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis

Altmetrics

Related Journals